相似文献
1
Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
Clin Exp Immunol. 1982 Dec;50(3):596-600.
2
Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.
Clin Exp Immunol. 1984 Sep;57(3):743-51.
3
[Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
Nouv Presse Med. 1974 Dec 28;3(45):2707-11.
4
IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
Ann Clin Lab Sci. 1989 Jan-Feb;19(1):27-37.
5
Asymptomatic (benign) monoclonal gammopathy--a study of 100 patients.
Ann Clin Lab Sci. 1977 Jul-Aug;7(4):335-43.
6
[IgG-K benign monoclonal gammopathy, IgG-K multiple myeloma and Bence Jones-L multiple myeloma in three brothers].
Rinsho Byori. 1988 Feb;36(2):233-6.
7
Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Ann Hematol. 2005 Sep;84(9):588-93. doi: 10.1007/s00277-005-1047-z. Epub 2005 May 10.
8
Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity.
Clin Exp Immunol. 1981 Sep;45(3):544-51.
9
The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
Biomedicine. 1975 Jan;22(1):41-8.
10
Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Immunology. 1985 May;55(1):45-57.
引用本文的文献
1
Lymphocyte subsets in the peripheral blood of patients with multiple myeloma and benign monoclonal gammopathy.
Klin Wochenschr. 1983 Aug 15;61(16):819-21. doi: 10.1007/BF01496728.
2
Detection and identification of serum monoclonal immunoglobulin by immunoisoelectric focusing. Limits of sensitivity and use during relapse of multiple myeloma.
J Clin Pathol. 1984 Mar;37(3):255-62. doi: 10.1136/jcp.37.3.255.
3
Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.
Clin Exp Immunol. 1984 Sep;57(3):743-51.
4
Bone-marrow plasmocytosis--an immunohistological study.
Blut. 1986 Jul;53(1):11-9. doi: 10.1007/BF00320578.
5
Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry.
Virchows Arch A Pathol Anat Histopathol. 1988;412(6):553-62. doi: 10.1007/BF00844291.
6
Antigen stimulated IgM secretion by circulating B lymphocytes in patients with benign and malignant IgG gammopathy. Relationship to stage of disease.
Clin Exp Immunol. 1989 Jan;75(1):12-7.
本文引用的文献
1
Smoldering multiple myeloma.
N Engl J Med. 1980 Jun 12;302(24):1347-9. doi: 10.1056/NEJM198006123022405.
2
Circulating immunoglobulin-secreting cells in patients with plasma cell dyscrasia.
Blood. 1980 Apr;55(4):590-4.
3
A plaque assay to enumerate circulating Ig-secreting cells of each type of the different Ig classes.
Blood. 1980 Aug;56(2):199-202.
4
Three cases of multiple myeloma in which the preclinical asymptomatic phases persisted throughout 15 to 24 years.
Br J Cancer. 1971 Sep;25(3):417-22. doi: 10.1038/bjc.1971.53.
5
Clinical classification of plasma cell myeloma.
Arch Intern Med. 1975 Jan;135(1):139-43.
6
Monitoring myelomatosis.
Arch Intern Med. 1975 Jan;135(1):125-30.
7
Management and prognosis of multiple myeloma.
Mayo Clin Proc. 1976 Dec;51(12):751-60.
8
Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases.
Clin Immunol Immunopathol. 1978 Jun;10(2):168-74. doi: 10.1016/0090-1229(78)90024-7.
Zotero 插件